Shingrix® is indicated for prevention of herpes zoster (“zoster” or shingles) and postherpetic neuralgia (PHN), in:
̵ Adults 50 years of age or older.
̵ Adults 18 years of age or older at increased risk of herpes zoster
Individuals should receive two doses of 0.5mL each: an initial dose followed by a second dose 2 months later.